Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase 2/3 1Phase 1/2 1

Status

Terminated 3Completed 3

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 3Lymphoid 3CNS 1

Conditions

Multiple Myeloma 3Lymphoma, Follicular 2Lymphoma, B-Cell 2Smoldering Multiple Myeloma 1Recurrence 1Meningeal Carcinomatosis 1Lymphoma 1Hodgkin Disease 1Disease Progression 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Has results × Transplantation, Autologous × Clear all
NCT00801216 2024-12-10

SCNSL1

IRCCS San Raffaele

Phase 2 Completed
40 enrolled 11 charts
CNSLymphoid

Lymphoma, B-Cell, Meningeal Carcinomatosis

NCT02043847 2024-11-13

BMT-03

University of Illinois at Chicago

Phase 1 Completed
12 enrolled 12 charts
Plasma cell

Multiple Myeloma, Recurrence, Disease Progression

NCT00096460 2023-01-05

BMT CTN 0202

Medical College of Wisconsin

Phase 2/3 Terminated
30 enrolled 5 charts
Lymphoid

Lymphoma, Follicular

NCT01141712 2023-01-04

Autologous Transplant in HIV Patients (BMT CTN 0803)

Medical College of Wisconsin

Phase 2 Completed
43 enrolled 21 charts
Lymphoid

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell

NCT02043860 2019-10-14

BMT-02

University of Illinois at Chicago

Phase 1 Terminated
3 enrolled 5 charts
Plasma cell

Multiple Myeloma

NCT02353572 2015-03-09

Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma

University of Colorado, Denver

Phase 1/2 Terminated
3 enrolled 5 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡